Clinical Trials/Research
As a Clinical Research Affiliate with the Cancer Institute of New Jersey (CINJ) we are an active participant in clinical research trials. Associating with this world-class organization provides our patients the benefit from cutting edge research and disease specific treatment programs.

Through CINJ, we participate in the study of Tamoxifen and Raloxifene (STAR) Trail, a nationwide study comparing the efficacy of these drugs in the prevention of breast cancer in high-risk women.

For eligibility data or forther information on our clinical trials, please contact Oncology Program Manager, Ann Chawner (achawner@rbmc.org) at (732) 324-5079.

NJ Cancer Trial Connect
NJ Cancer Trial Connect, or NJCTC, matches the cancer treatment trials in our state with your medical profile. You can search for studies of interest to you and your family or others you may know.

Upcoming Cancer Patient Support Group Meetings